* Theodor Kocher Institute, University of Bern, Bern, Switzerland; and
The Biomedical Research Centre and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada
Correspondence: Pius Loetscher, Theodor Kocher Institute, University of Bern, P.O. Box 99, CH-3000 Bern 9, Switzerland. E-mail: pius.loetscher{at}tki.unibe.ch
Since the discovery of interleukin-8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven-transmembrane domain, G protein-coupled receptors. Eighteen such receptors have been identified so far. Studies on structure-activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2-terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2-terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2-terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.
Key Words: chemokine receptors • natural antagonists • inflammation • chemotaxis
This article has been cited by other articles:
 |
|
 |
|
  N. Giuliani, G. Lisignoli, S. Colla, M. Lazzaretti, P. Storti, C. Mancini, S. Bonomini, C. Manferdini, K. Codeluppi, A. Facchini, et al. CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3{alpha} and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions Cancer Res., August 15, 2008; 68(16): 6840 - 6850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Van Lint and C. Libert Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation J. Leukoc. Biol., December 1, 2007; 82(6): 1375 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cittera, M. Leidi, C. Buracchi, F. Pasqualini, S. Sozzani, A. Vecchi, J. D. Waterfield, M. Introna, and J. Golay The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab J. Immunol., May 15, 2007; 178(10): 6616 - 6623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Garrood, L. Lee, and C. Pitzalis Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways Rheumatology, March 1, 2006; 45(3): 250 - 260. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Balabanian, B. Lagane, S. Infantino, K. Y. C. Chow, J. Harriague, B. Moepps, F. Arenzana-Seisdedos, M. Thelen, and F. Bachelerie The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes J. Biol. Chem., October 21, 2005; 280(42): 35760 - 35766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Casarosa, M. Waldhoer, P. J. LiWang, H. F. Vischer, T. Kledal, H. Timmerman, T. W. Schwartz, M. J. Smit, and R. Leurs CC and CX3C Chemokines Differentially Interact with the N Terminus of the Human Cytomegalovirus-encoded US28 Receptor J. Biol. Chem., February 4, 2005; 280(5): 3275 - 3285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Jones, N. J. Hannan, T. J. Kaitu'u, J. Zhang, and L. A. Salamonsen Identification of Chemokines Important for Leukocyte Recruitment to the Human Endometrium at the Times of Embryo Implantation and Menstruation J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6155 - 6167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Moser and K Willimann Chemokines: role in inflammation and immune surveillance Ann Rheum Dis, November 1, 2004; 63(suppl_2): ii84 - ii89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dajotoy, P. Andersson, A. Bjartell, C.-G. Lofdahl, H. Tapper, and A. Egesten Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-{gamma} J. Leukoc. Biol., September 1, 2004; 76(3): 685 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Forssmann, I. Hartung, R. Balder, B. Fuchs, S. E. Escher, N. Spodsberg, Y. Dulkys, M. Walden, A. Heitland, A. Braun, et al. n-Nonanoyl-CC Chemokine Ligand 14, a Potent CC Chemokine Ligand 14 Analogue That Prevents the Recruitment of Eosinophils in Allergic Airway Inflammation J. Immunol., September 1, 2004; 173(5): 3456 - 3466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fernando, C. Chin, J. Rosgen, and K. Rajarathnam Dimer Dissociation Is Essential for Interleukin-8 (IL-8) Binding to CXCR1 Receptor J. Biol. Chem., August 27, 2004; 279(35): 36175 - 36178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rajagopalan and K. Rajarathnam Ligand Selectivity and Affinity of Chemokine Receptor CXCR1: ROLE OF N-TERMINAL DOMAIN J. Biol. Chem., July 16, 2004; 279(29): 30000 - 30008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ogilvie, S. Thelen, B. Moepps, P. Gierschik, A. C. da Silva Campos, M. Baggiolini, and M. Thelen Unusual Chemokine Receptor Antagonism Involving a Mitogen-Activated Protein Kinase Pathway J. Immunol., June 1, 2004; 172(11): 6715 - 6722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Petkovic, C. Moghini, S. Paoletti, M. Uguccioni, and B. Gerber Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5: A HUMAN CHEMOKINE WITH A REGULATORY ROLE J. Biol. Chem., May 28, 2004; 279(22): 23357 - 23363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vroon, C. J. Heijnen, R. Raatgever, I. P. Touw, R. E. Ploemacher, R. T. Premont, and A. Kavelaars GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo J. Leukoc. Biol., April 1, 2004; 75(4): 698 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Peterson, E. S. Elgin, T. J. Nelson, F. Zhang, T. J. Hoeger, R. J. Linhardt, and B. F. Volkman Identification and Characterization of a Glycosaminoglycan Recognition Element of the C Chemokine Lymphotactin J. Biol. Chem., March 26, 2004; 279(13): 12598 - 12604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Warke, K. Xhaja, K. J. Martin, M. F. Fournier, S. K. Shaw, N. Brizuela, N. de Bosch, D. Lapointe, F. A. Ennis, A. L. Rothman, et al. Dengue Virus Induces Novel Changes in Gene Expression of Human Umbilical Vein Endothelial Cells J. Virol., November 1, 2003; 77(21): 11822 - 11832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ogilvie, S. Paoletti, I. Clark-Lewis, and M. Uguccioni Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes Blood, August 1, 2003; 102(3): 789 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vulcano, S. Struyf, P. Scapini, M. Cassatella, S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, et al. Unique Regulation of CCL18 Production by Maturing Dendritic Cells J. Immunol., April 1, 2003; 170(7): 3843 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Clark-Lewis, I. Mattioli, J.-H. Gong, and P. Loetscher Structure-Function Relationship between the Human Chemokine Receptor CXCR3 and Its Ligands J. Biol. Chem., January 3, 2003; 278(1): 289 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Rosenfeld Leukocyte Recruitment Into Developing Atherosclerotic Lesions: The Complex Interaction Between Multiple Molecules Keeps Getting More Complex Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 361 - 363. [Full Text] [PDF]
|
|
